Optimal Conditions for Oxygenated Subnormothermic Machine Perfusion for Liver Grafts Using a Novel Perfusion Device.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 01 10 2021
revised: 30 11 2021
accepted: 29 12 2021
pubmed: 7 2 2022
medline: 1 4 2022
entrez: 6 2 2022
Statut: ppublish

Résumé

Liver transplantation from donors after cardiac death (DCD) resolves donor shortages. We investigated the optimal time for subnormothermic oxygenated perfusion in DCD liver transplantation. Ten F1 pigs (body weight: 27-32 kg) were allocated to 2 groups: the heart beating group (n = 6), from which livers were retrieved while the heart was beating, and the donation after cardiac death (DCD) group (n = 4), in which liver retrieval was performed on pigs under apnea-induced cardiac arrest for 20 minutes. In both groups, the livers were kept in cold storage for 2 hours after retrieval and perfused with a subnormothermic oxygenated Krebs-Henseleit buffer for 120 minutes. We used a novel perfusion device, which can set maximum perfusion pressures of arteries and portal vein, developed by Asahikawa Medical University and Chuo Seiko Co. Bile production, liver enzymes, and inflammatory cytokines were measured and the sinusoidal space, using tissue specimens taken from liver grafts, was measured at 30, 60, 90, and 120 minutes after the start of perfusion. Bile production peaked at 90 minutes. Significantly higher levels of liver enzymes and inflammatory cytokines were found in the DCD group (P < .05). The release of liver enzymes peaked at 60 minutes and that of inflammatory cytokines peaked at 90 minutes. The hepatic sinusoidal space was wide at 90 minutes and narrowed after 120 minutes. The results suggest that subnormothermic oxygenation perfusion may maintain optimal graft condition until around 90 minutes and perfusion for more than 120 minutes may be counterproductive.

Sections du résumé

BACKGROUND BACKGROUND
Liver transplantation from donors after cardiac death (DCD) resolves donor shortages.
PURPOSE OBJECTIVE
We investigated the optimal time for subnormothermic oxygenated perfusion in DCD liver transplantation.
METHODS METHODS
Ten F1 pigs (body weight: 27-32 kg) were allocated to 2 groups: the heart beating group (n = 6), from which livers were retrieved while the heart was beating, and the donation after cardiac death (DCD) group (n = 4), in which liver retrieval was performed on pigs under apnea-induced cardiac arrest for 20 minutes. In both groups, the livers were kept in cold storage for 2 hours after retrieval and perfused with a subnormothermic oxygenated Krebs-Henseleit buffer for 120 minutes. We used a novel perfusion device, which can set maximum perfusion pressures of arteries and portal vein, developed by Asahikawa Medical University and Chuo Seiko Co. Bile production, liver enzymes, and inflammatory cytokines were measured and the sinusoidal space, using tissue specimens taken from liver grafts, was measured at 30, 60, 90, and 120 minutes after the start of perfusion.
RESULTS RESULTS
Bile production peaked at 90 minutes. Significantly higher levels of liver enzymes and inflammatory cytokines were found in the DCD group (P < .05). The release of liver enzymes peaked at 60 minutes and that of inflammatory cytokines peaked at 90 minutes. The hepatic sinusoidal space was wide at 90 minutes and narrowed after 120 minutes.
CONCLUSIONS CONCLUSIONS
The results suggest that subnormothermic oxygenation perfusion may maintain optimal graft condition until around 90 minutes and perfusion for more than 120 minutes may be counterproductive.

Identifiants

pubmed: 35123792
pii: S0041-1345(21)00951-9
doi: 10.1016/j.transproceed.2021.12.025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-224

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Hiroyasu Nishimaki (H)

Department of Gastroenterological Surgery, Tohoku University Graduate School, Miyagi, Japan. Electronic address: h.nishimaki@surg.med.tohoku.ac.jp.

Shigehito Miyagi (S)

Department of Gastroenterological Surgery, Tohoku University Graduate School, Miyagi, Japan.

Toshiaki Kashiwadate (T)

Department of Gastroenterological Surgery, Tohoku University Graduate School, Miyagi, Japan.

Kazuaki Tokodai (K)

Department of Gastroenterological Surgery, Tohoku University Graduate School, Miyagi, Japan.

Atsushi Fujio (A)

Department of Gastroenterological Surgery, Tohoku University Graduate School, Miyagi, Japan.

Koji Miyazawa (K)

Department of Gastroenterological Surgery, Tohoku University Graduate School, Miyagi, Japan.

Kengo Sasaki (K)

Department of Gastroenterological Surgery, Tohoku University Graduate School, Miyagi, Japan.

Takashi Kamei (T)

Department of Gastroenterological Surgery, Tohoku University Graduate School, Miyagi, Japan.

Michiaki Unno (M)

Department of Gastroenterological Surgery, Tohoku University Graduate School, Miyagi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH